Malgorzata Broncel

Malgorzata Broncel

Auto-generated profile, based on publicly available information

Malgorzata Broncel

Signalling in Apicomplexan Parasites Laboratory, The Francis Crick Institute

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 September 2014 in Nature Communications
Verified
Journal Article
Open access
ETEmmanuelle Thinon
Emmanuelle Thinon
RSRemigiusz A. Serwa
Remigiusz A. Serwa
MBMalgorzata Broncel
Malgorzata Broncel
JBJames A. Brannigan
James A. Brannigan
UBUte Brassat
Ute Brassat
ETEdward W. Tate
Edward W. Tate
Protein N-myristoylation is a ubiquitous co- and post-translational modification that has been implicated in the development and progression of a range of human diseases. Here, we report the global N-myristoylated proteome in human cells determined using quantitative chemical proteomics combined with potent and specific human N-myristoyltransferase (NMT) inhibition. Global quantification of N-myristoylation during normal growth or apoptosis allowed the identification of >100 N-myristoylated proteins, >95% of which are identified for the first time at endogenous levels. Furthermore, quantitative dose response for inhibition of N-myristoylation is determined for >70 substrates simultaneously across the proteome. Small-molecule inhibition through a conserved substrate-binding pocket is also demonstrated by solving the crystal structures of inhibitor-bound NMT1 and NMT2. The presented data substantially expand the known repertoire of co- and post-translational N-myristoylation in addition to validating tools for the pharmacological inhibition of NMT in living cells.

22 December 2013 in Nature Chemistry
Verified
Journal Article
Closed access
PDF file
MWMegan H. Wright
Megan H. Wright
BCBarbara Clough
Barbara Clough
MRMark D. Rackham
Mark D. Rackham
KRKaveri Rangachari
Kaveri Rangachari
JBJames A. Brannigan
James A. Brannigan
ETEdward W. Tate
Edward W. Tate

16 February 2011 in Molecular BioSystems
Verified
Journal Article
Closed access
PDF file
CSCaroline Smet-Nocca
Caroline Smet-Nocca
MBMalgorzata Broncel
Malgorzata Broncel
JWJean-Michel Wieruszeski
Jean-Michel Wieruszeski
CTCaroline Tokarski
Caroline Tokarski
XHXavier Hanoulle
Xavier Hanoulle
CHChristian P. R. Hackenberger
Christian P. R. Hackenberger
Phosphorylation of the microtubule-associated Tau protein plays a major role in the regulation of its activity of tubulin polymerization and/or stabilization of microtubule assembly. A dysregulation of the phosphorylation/dephosphorylation balance leading to the hyperphosphorylation of Tau proteins in neurons is thought to favor their aggregation into insoluble filaments. This in turn might underlie neuronal death as encountered in many neurodegenerative disorders, including Alzheimer's disease. Another post-translational modification, the O-linked β-N-acetylglucosaminylation (O-GlcNAcylation), controls the phosphorylation state of Tau, although the precise mechanism is not known. Moreover, analytical difficulties have hampered the precise localization of the O-GlcNAc sites on Tau, except for the S400 site that was very recently identified on the basis of ETD-FT-MS. Here, we identify three O-GlcNAc sites by screening a library of small peptides sampling the proline-rich, the microtubule-associated repeats and the carboxy-terminal domains of Tau as potential substrates for the O-β-N-acetylglucosaminyltransferase (OGT). The in vitro activity of the nucleocytoplasmic OGT was assessed by tandem mass spectrometry and NMR spectroscopy. Using phosphorylated peptides, we establish the relationship between phosphate and O-GlcNAc incorporation at these sites. Phosphorylation of neighboring residues S396 and S404 was found to decrease significantly S400 O-GlcNAcylation. Reciprocally, S400 O-GlcNAcylation reduces S404 phosphorylation by the CDK2/cyclinA3 kinase and interrupts the GSK3β-mediated sequential phosphorylation process.

25 March 2015 in Angewandte Chemie International Edition
Verified
Journal Article
Open access
PDF file
MBMalgorzata Broncel
Malgorzata Broncel
RSRemigiusz A. Serwa
Remigiusz A. Serwa
PCPaulina Ciepla
Paulina Ciepla
EKEberhard Krause
Eberhard Krause
MDMargaret J. Dallman
Margaret J. Dallman
ETEdward W. Tate
Edward W. Tate
Novel multifunctional reagents were applied in combination with a lipid probe for affinity enrichment of myristoylated proteins and direct detection of lipid‐modified tryptic peptides by mass spectrometry. This method enables high‐confidence identification of the myristoylated proteome on an unprecedented scale in cell culture, and allowed the first quantitative analysis of dynamic changes in protein lipidation during vertebrate embryonic development.

13 April 2020 in Nature Microbiology
Verified
Journal Article
Closed access
PDF file
HDHeledd Davies
Heledd Davies
HBHugo Belda
Hugo Belda
MBMalgorzata Broncel
Malgorzata Broncel
XYXingda Ye
Xingda Ye
CBClaudine Bisson
Claudine Bisson
MTMoritz Treeck
Moritz Treeck

1 February 2016 in Molecular & Cellular Proteomics
Verified
Journal Article
Open access
PDF file
MBMalgorzata Broncel
Malgorzata Broncel
RSRemigiusz A. Serwa
Remigiusz A. Serwa
TBTom D. Bunney
Tom D. Bunney
MKMatilda Katan
Matilda Katan
ETEdward W. Tate
Edward W. Tate
AMPylation of mammalian small GTPases by bacterial virulence factors can be a key step in bacterial infection of host cells, and constitutes a potential drug target. This posttranslational modification also exists in eukaryotes, and AMP transferase activity was recently assigned to HYPE Filamentation induced by cyclic AMP domain containing protein (FICD) protein, which is conserved from Caenorhabditis elegans to humans. In contrast to bacterial AMP transferases, only a small number of HYPE substrates have been identified by immunoprecipitation and mass spectrometry approaches, and the full range of targets is yet to be determined in mammalian cells. We describe here the first example of global chemoproteomic screening and substrate validation for HYPE-mediated AMPylation in mammalian cell lysate. Through quantitative mass-spectrometry-based proteomics coupled with novel chemoproteomic tools providing MS/MS evidence of AMP modification, we identified a total of 25 AMPylated proteins, including the previously validated substrate endoplasmic reticulum (ER) chaperone BiP (HSPA5), and also novel substrates involved in pathways of gene expression, ATP biosynthesis, and maintenance of the cytoskeleton. This dataset represents the largest library of AMPylated human proteins reported to date and a foundation for substrate-specific investigations that can ultimately decipher the complex biological networks involved in eukaryotic AMPylation.